Clinical Manifestation and Outcomes of Neuroretinitis in Korea
Author(s) -
Su Gyeong Jang,
Kang Yeun Pak,
Han Jo Kwon,
Seung Min Lee,
Sung Who Park,
Ik Soo Byon,
Ji Eun Lee
Publication year - 2017
Publication title -
journal of the korean ophthalmological society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.12
H-Index - 2
eISSN - 2092-9374
pISSN - 0378-6471
DOI - 10.3341/jkos.2017.58.2.156
Subject(s) - medicine , optometry , ophthalmology
Purpose: In the present study, the clinical characteristics and outcomes of neuroretinitis in Korea were investigated. Methods: Seven consecutive patients with neuroretinitis from 2012 to 2015 were retrospectively reviewed. Results: The present study included 9 eyes of 7 patients. The subjects consisted of 5 males and 2 females and the mean age was 45.1 ± 13.2 years. Two patients had Influenza-like symptoms and the others had no specific general symptoms. The mean best corrected visual acuity was logMAR 0.48 ± 0.55 (0-1.6) on the initial visit. Four patients 40 years of age or under had no abnormal findings in laboratory work-up. Conversely, 3 patients over 40 years of age were positive for Toxocara based on enzyme-linked immunosorbent assay (ELISA). Two of 3 patients positive for Toxocara were treated with albendazole and 1was not. Eight eyes had good visual recovery over 20/30 except for 1 patient who did not take the albendazole despite being positive for Toxocara detected using ELISA. Conclusions: Three of 7 patients with neuroretinitis in Korea showed positive results forToxocara based on ELISA. In cases with seropositive Toxocara ELISA results, albendazole treatment should be considered. J Korean Ophthalmol Soc 2017;58(2):156-164
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom